翰思艾泰-B(03378.HK)与TwinEdge Bioscience 开展AI药物研发合作

智通财经07-02 23:02

【翰思艾泰-B(03378.HK)与TwinEdge Bioscience 开展AI药物研发合作】智通财经APP讯，翰思艾泰-B(03378.HK)发布公告，本公司前期与总部位于瑞士的一家基于独有计算生物学技术的前沿生物科技公司TwinEdge Bioscience所签署的合作协议(协议)已针对该合作项目开展研究，双方依托人工智能技术围绕翰思艾泰的核心双特异性抗体治疗候选药物HX009展开转化医学研究。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2648714686?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-02 23:02","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2648714686","market":"hk","top_or_hot":-1,"title":"翰思艾泰-B(03378.HK)与TwinEdge Bioscience 开展AI药物研发合作","media":"智通财经","content":"<html><body><div>\n<div>\n<b>【翰思艾泰-B(03378.HK)与TwinEdge Bioscience 开展AI药物研发合作】</b>智通财经APP讯，翰思艾泰-B(03378.HK)发布公告，本公司前期与总部位于瑞士的一家基于独有计算生物学技术的前沿生物科技公司TwinEdge \n\nBioscience所签署的合作协议(协议)已针对该合作项目开展研究，双方依托人工智能技术围绕翰思艾泰的核心双特异性抗体治疗候选药物HX009展开转化医学研究。                </div>\n</div></body></html>","source":"live_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>翰思艾泰-B(03378.HK)与TwinEdge Bioscience 开展AI药物研发合作</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n翰思艾泰-B(03378.HK)与TwinEdge Bioscience 开展AI药物研发合作\n</h2>\n\n<h4 class=\"meta\">\n\n</h4>\n\n</header>\n<article>\n<html><body><div>\n<div>\n<b>【翰思艾泰-B(03378.HK)与TwinEdge Bioscience 开展AI药物研发合作】</b>智通财经APP讯，翰思艾泰-B(03378.HK)发布公告，本公司前期与总部位于瑞士的一家基于独有计算生物学技术的前沿生物科技公司TwinEdge \n\nBioscience所签署的合作协议(协议)已针对该合作项目开展研究，双方依托人工智能技术围绕翰思艾泰的核心双特异性抗体治疗候选药物HX009展开转化医学研究。                </div>\n</div></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.zhitongcaijing.com/immediately.html?type=ganggu\">智通财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1173","symbol_name":"海港与服务","start_time":0,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","article_id":"2648714686","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2648714686","pubTimestamp":1783004573,"columns":[],"sourceInfo":{"source_id":"live_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【翰思艾泰-B(03378.HK)与TwinEdge Bioscience 开展AI药物研发合作】智通财经APP讯，翰思艾泰-B(03378.HK)发布公告，本公司前期与总部位于瑞士的一家基于独有计算","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1173":"海港与服务","03378":"翰思艾泰-B","BK1535":"港口运输股","BK1161":"生物科技"},"translate_title":"Hansi Aitai-B (03378.HK) and TwinEdge Bioscience collaborate on AI drug research and development","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03378":1.5},"content_text":"【翰思艾泰-B(03378.HK)与TwinEdge Bioscience 开展AI药物研发合作】智通财经APP讯，翰思艾泰-B(03378.HK)发布公告，本公司前期与总部位于瑞士的一家基于独有计算生物学技术的前沿生物科技公司TwinEdge \n\nBioscience所签署的合作协议(协议)已针对该合作项目开展研究，双方依托人工智能技术围绕翰思艾泰的核心双特异性抗体治疗候选药物HX009展开转化医学研究。","kind":"live","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2648714686","isCrawlerRequest":true}